T-cell metabolism in autoimmune disease

Area of Science:

• Immunometabolism
• Autoimmune diseases
• Cellular metabolism

Background:

• Cancer cells exhibit the Warburg effect, relying on high glycolytic flux.
• Immune cells, particularly T cells, also utilize aerobic glycolysis upon activation.
• Dysfunctional T cells in autoimmune diseases like rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE) present unique metabolic signatures.

Purpose of the Study:

• To investigate the specific metabolic alterations in T cells from patients with RA and SLE.
• To compare the metabolic profiles of these autoimmune T cells with those of cancer cells exhibiting the Warburg effect.
• To identify potential metabolic biomarkers and therapeutic targets for autoimmune diseases.

Main Methods:

• Analysis of metabolic profiles, including adenosine triphosphate, lactate, NADPH, and lipid metabolism, in T cells from RA and SLE patients.
• Comparison of glycolytic flux and tricarboxylic acid cycle activity.
• Investigation of glycosphingolipid production and its impact on T cell signaling pathways.

Main Results:

• RA T cells display an 'anti-Warburg effect' with low ATP and lactate, and high NADPH, due to insufficient phosphofructokinase activity.
• SLE T cells show excess reactive oxygen species and lipid metabolism defects, with increased glycosphingolipids affecting signaling and leading to hyperproliferation.
• Metabolic modifications in autoimmune diseases are heterogeneous and context-dependent, varying across different disease states.

Conclusions:

• T cell metabolic signatures in RA and SLE are distinct and contribute to their dysfunction.
• Understanding these metabolic differences, distinct from cancer's Warburg effect, is crucial.
• Metabolic pathways in autoimmune diseases represent promising avenues for biomarker development and targeted therapies.